Table 7

Percentage (95% CI) of respondents rating each type of medication as "harmful" for the person described in the vignette

Medication

Country

Depression Vignette

Depression/Suicidal Vignette

Early Schizophrenia Vignette

Chronic Schizophrenia Vignette


Vitamins, minerals

Australia

4.4 (2.9–6.7)

5.4 (3.7–7.9)

5.8 (4.1–8.4)

6.4 (4.5–9.0)

Japan

14.6 (11.5–17.7)

13.8 (10.8–16.8)

14.6 (11.5–17.7)

14.8 (11.7–17.9)

Pain relievers

Australia

37.7 (33.0–42.6)

37.3 (33.1–41.7)

38.9 (34.6–43.4)

34.5 (30.0–39.3)

Japan

43.4 (39.0–47.8)

42.6 (38.3–46.9)

36.6 (32.4–40.8)

35.6 (31.4–39.8)

Antidepressants

Australia

27.5 (23.5–31.8)

23.4 (19.8–27.4)

22.6 (19.2–26.5)

29.3 (25.2–33.8)

Japan

18.2 (14.8–21.6)

21.2 (17.6–24.8)

15.2 (12.0–18.4)

10.6 (7.9–13.3)

Antibiotics

Australia

38.3 (33.4–43.4)

37.8 (33.0–42.8)

35.9 (31.5–40.4)

36.9 (32.4–41.7)

Japan

29.8 (25.8–33.8)

37.6 (33.3–41.9)

29.0 (25.0–33.0)

22.8 (19.1–26.5)

Sleeping pills

Australia

49.6 (44.9–54.3)

50.3 (45.9–54.7)

53.1 (48.2–57.9)

58.8 (54.3–63.1)

Japan

27.0 (23.1–30.9)

27.8 (23.9–31.7)

30.0 (26.0–34.0)

27.0 (23.1–30.9)

Antipsychotics

Australia

48.3 (43.5–53.1)

40.4 (35.9–45.0)

24.5 (20.6–28.8)

24.5 (20.9–28.5)

Japan

19.0 (15.5–22.5)

23.8 (20.1–27.5)

17.4 (14.1–20.7)

8.4 (6.0–10.8)

Tranquillizers

Australia

60.4 (55.8–64.8)

60.1 (55.5–64.5)

47.5 (42.9–52.2)

55.7 (50.9–60.4)

Japan

15.8 (12.6–19.0)

17.6 (14.3–20.9)

13.4 (10.4–16.4)

9.4 (6.8–12.0)


Jorm et al. BMC Medicine 2005 3:12   doi:10.1186/1741-7015-3-12

Open Data